Astepro and Pataday drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Astepro (azelastine hydrochloride) and Pataday (olopatadine hydrochloride). Common drug interactions include constipation among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Astepro and Pataday. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Astepro?

Astepro has active ingredients of azelastine hydrochloride. It is often used in allergies. eHealthMe is studying from 3,336 Astepro users. Check the latest studies of Astepro.

What is Pataday?

Pataday has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 8,288 Pataday users. Check the latest studies of Pataday.



On Jul, 10, 2026

35 people who take Astepro and Pataday together, and have interactions are studied.

Astepro and Pataday drug interactions.

What are the common drug interactions of Astepro and Pataday, by gender? *:

female:

  1. Constipation
  2. Fatigue (feeling of tiredness)
  3. Headache (pain in head)
  4. Arthralgia (joint pain)
  5. Dizziness
  6. Myalgia (muscle pain)
  7. Pruritus (severe itching of the skin)
  8. Adenoma benign (non-cancerous tumour -secreting)
  9. Blood pressure increased
  10. Dry skin

male:

  1. Diarrhoea
  2. Asthenia (weakness)
  3. Migraine (headache)
  4. Urinary tract infection
  5. Chills (felling of cold)
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Fatigue (feeling of tiredness)
  8. Nausea (feeling of having an urge to vomit)
  9. Blood pressure systolic increased
  10. Bradycardia (abnormally slow heart action)

What are the common drug interactions of Astepro and Pataday, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Drug ineffective
  2. Optic neuritis (optic nerve inflammation)
  3. Pruritus (severe itching of the skin)
  4. Arthralgia (joint pain)
  5. Chest discomfort
  6. Chest pain
  7. Dry mouth
  8. Dry skin
  9. Dyspnoea (difficult or laboured respiration)
  10. Ear discomfort

40-49:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  3. Fatigue (feeling of tiredness)
  4. Influenza like illness
  5. Injection site reaction
  6. Myalgia (muscle pain)

50-59:

  1. Skin irritation
  2. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  3. Staphylococcal infection (an infection with staphylococcus bacteria)
  4. Streptococcal infection
  5. Syncope (loss of consciousness with an inability to maintain postural tone)
  6. Thyroid cancer
  7. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  8. Arthralgia (joint pain)
  9. Asthma
  10. Corneal disorder

60+:

  1. Diarrhoea
  2. Dizziness
  3. Transaminases increased
  4. Uveitis (inflammation of the uvea)
  5. Acquired oesophageal web (structural abnormalities in the oesophagus)
  6. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  7. Blood pressure systolic increased
  8. Bradycardia (abnormally slow heart action)
  9. Cough
  10. Dysphagia (a condition in which swallowing is difficult or painful)

What are the existing conditions these people have? *

  1. Asthma: 12 people, 34.29%
  2. Stress And Anxiety: 5 people, 14.29%
  3. High Blood Pressure: 5 people, 14.29%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 14.29%
  5. Seasonal Allergy (allergic condition due to certain season): 4 people, 11.43%
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 11.43%
  7. Migraine (headache): 4 people, 11.43%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 11.43%
  9. Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 3 people, 8.57%
  10. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Astepro and Pataday?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Astepro and Pataday:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Astepro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pataday:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Astepro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pataday and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on azelastine hydrochloride and olopatadine hydrochloride (the active ingredients of Astepro and Pataday, respectively), and Astepro and Pataday (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: